Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758121 · ClinicalTrials.gov registry record
Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients
A clinical trial, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- 56
- Enrollment target
NCT00758121: Clinical Trial study, sponsored by Boston Scientific Corporation.
NCT00758121 is a clinical trial that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00758121 was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The objective of the study is to determine if there is any relationship between respiratory rate and Heart Failure events.
Interventions
- DEVICE Cardiac Resynchronization Therapy Defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-10 |
Why NCT00758121 stopped before completion
NCT00758121 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy Defibrillator is the first listed.
NCT00758121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00758121 about?
NCT00758121 is a clinical study titled "Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients". The objective of the study is to determine if there is any relationship between respiratory rate and Heart Failure events.
What is the current status of trial NCT00758121?
This trial is currently terminated. The enrollment target is 56 participants. The study started on 2008-11. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00758121?
The interventions under investigation include: Cardiac Resynchronization Therapy Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00758121?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia